ExaWizards Inc. (JP:4259)
:4259
Top Page
ExaWizards Inc.
(4259)
Select Model
Select Model
Rating:45Neutral
Price Target:
¥664.00
▲(4.24% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by weaker financial quality (sharp FY2025 loss expansion and higher leverage despite improved cash flow) and bearish technical positioning (below key moving averages with negative MACD). Valuation is also a headwind due to a high P/E and no provided dividend yield.
Positive Factors
Revenue growth & gross margins
Multi-year revenue growth near 12% combined with sustained gross margins around 56–64% indicate durable product economics and market demand. That mix supports scalable revenue expansion and pricing leverage, enabling reinvestment in R&D and sales to drive medium-term organic growth if operating costs are contained.
Negative Factors
Worsening profitability
Net margin deteriorating to roughly -26% in FY2025 from about -7% signals operating cost growth or margin pressure outpacing top-line gains. Persistent deep losses erode equity, limit the firm’s capacity to self-fund expansion, and increase dependence on sustained positive cash flow or external capital to support medium-term strategic initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth & gross margins
Multi-year revenue growth near 12% combined with sustained gross margins around 56–64% indicate durable product economics and market demand. That mix supports scalable revenue expansion and pricing leverage, enabling reinvestment in R&D and sales to drive medium-term organic growth if operating costs are contained.
Read all positive factors
ExaWizards Inc. (4259) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥59.30B
Dividend YieldN/A
Average Volume (3M)1.54M
Price to Earnings (P/E)43.6
Beta (1Y)1.02
Revenue Growth8.98%
EPS Growth-581.59%
CountryJP
Employees548
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)3.65
Shares Outstanding87,084,500
10 Day Avg. Volume1,998,980
30 Day Avg. Volume1,537,346
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)10.12
Price to Sales (P/S)2.54
P/FCF Ratio49.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.9
Revenue Forecast (FY)¥13.44B
ExaWizards Inc. Business Overview & Revenue Model
Company Description
ExaWizards Inc. develops AI-enabled services for industrial innovation and social problems solutions in Japan. It operates through AI Platform and AI Products segments. The company provides AI platform services; and services for AI understanding, ...
How the Company Makes Money
ExaWizards Inc. generates revenue through the development and sales of AI-based products and services, including proprietary platforms tailored to industries such as healthcare and HR. Additionally, the company earns income from consulting service...
ExaWizards Inc. Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
38
Negative
Cash Flow
57
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.15B | 9.81B | 8.38B | 5.59B | 4.81B | 2.61B |
| Gross Profit | 6.25B | 5.67B | 4.69B | 3.14B | 3.05B | 1.66B |
| EBITDA | -1.42B | -1.75B | 67.00M | 359.00M | 90.00M | -441.13M |
| Net Income | -2.21B | -2.58B | -610.00M | -141.00M | -137.00M | -592.69M |
Balance Sheet | ||||||
| Total Assets | 7.46B | 7.11B | 10.13B | 7.96B | 7.89B | 3.69B |
| Cash, Cash Equivalents and Short-Term Investments | 3.85B | 3.01B | 3.49B | 5.23B | 5.54B | 2.34B |
| Total Debt | 2.48B | 2.55B | 2.85B | 310.00M | 345.22M | 815.00M |
| Total Liabilities | 4.35B | 4.57B | 5.14B | 1.34B | 1.26B | 1.30B |
| Stockholders Equity | 3.02B | 2.46B | 4.93B | 6.54B | 6.59B | 2.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 505.00M | -1.12B | -843.00M | -445.00M | -1.09B |
| Operating Cash Flow | 0.00 | 621.00M | -197.00M | 71.00M | 24.00M | -528.13M |
| Investing Cash Flow | 0.00 | -880.00M | -2.95B | -483.00M | -701.00M | -572.57M |
| Financing Cash Flow | 0.00 | -221.00M | 1.41B | 105.00M | 3.88B | 1.80B |
ExaWizards Inc. Technical Analysis
Positive
637.00
Price Trends
689.42
Negative
671.14
Positive
593.14
Positive
Market Momentum
3.04
Negative
54.29
Neutral
76.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4259, the sentiment is Positive. The current price of 637 is below the 20-day moving average (MA) of 641.25, below the 50-day MA of 689.42, and above the 200-day MA of 593.14, indicating a neutral trend. The MACD of 3.04 indicates Negative momentum. The RSI at 54.29 is Neutral, neither overbought nor oversold. The STOCH value of 76.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4259.
ExaWizards Inc. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | ¥13.17B | 37.90 | ― | ― | 25.41% | 9.69% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥8.82B | 33.78 | ― | ― | 60.41% | -27.67% | |
56 Neutral | ¥3.91B | 35.15 | ― | ― | 10.43% | -65.78% | |
52 Neutral | ¥12.93B | -90.49 | ― | ― | 16.29% | 93.98% | |
45 Neutral | ¥59.30B | 43.64 | ― | ― | 8.98% | -581.59% | |
44 Neutral | ¥25.10B | 35.20 | ― | ― | 36.08% | -7.71% |
* Technology Sector Average
JP:4259
ExaWizards Inc.
681.00
391.00
134.83%
JP:4382
HEROZ, Inc.
850.00
-67.00
-7.31%
JP:4425
Kudan, Inc.
2,221.00
1,076.00
93.97%
JP:4476
AI CROSS Inc
968.00
-680.00
-41.26%
JP:5572
Ridge-i Inc.
2,043.00
-274.00
-11.83%
JP:5586
Laboro.AI, Inc.
826.00
-104.00
-11.18%
ExaWizards Inc. Corporate Events
ExaWizards to Make SMFG Its Largest Shareholder via Third-Party Share Allotment
Mar 31, 2026
ExaWizards Inc. plans a significant change in its shareholder structure following a third-party allotment of new shares to Sumitomo Mitsui Financial Group (SMFG), a major Japanese financial conglomerate. After the transaction, SMFG is expected to ...
ExaWizards seals AI alliance with SMFG and issues new shares for 10% stake
Mar 31, 2026
ExaWizards Inc. has entered into a capital and business alliance with Sumitomo Mitsui Financial Group to accelerate AI-driven transformation and digitalization across the SMBC Group and the wider financial sector. The collaboration will center on ...
ExaWizards Launches AI-Native Systems Integration Subsidiary Exa Frontier Edge
Mar 12, 2026
ExaWizards Inc. has approved the creation of a wholly owned subsidiary, Exa Frontier Edge Inc., to develop and operate systems built from the ground up around AI agents and AI-driven development. The new company, capitalized at 300 million yen and...
ExaWizards Lifts Full-Year Earnings Outlook on Surging AI Product Demand
Mar 12, 2026
ExaWizards Inc. has raised its full-year consolidated earnings forecast for the fiscal year ending March 2026, citing stronger-than-expected performance in its AI Products Business. The company now projects total sales of ¥11.9 billion and op...
ExaWizards Transfers HR Tech Business to AI Subsidiary to Sharpen AX Focus
Feb 12, 2026
ExaWizards Inc. has approved a simplified absorption-type company split to transfer its HR Tech business, built around the exaBase DX Assessment Learning talent development service and newer AX-focused programs, to its wholly owned subsidiary Exa...
ExaWizards Unveils Q3 FY2026/3 Financial Results and Business Progress
Feb 12, 2026
ExaWizards Inc. released its financial results presentation for the third quarter of the fiscal year ending March 2026. The materials outline consolidated financial performance, segment progress, and business updates, indicating a structured discl...
ExaWizards Swings to Profit and Lifts Outlook on Strong Nine-Month Results
Feb 12, 2026
ExaWizards Inc. reported consolidated net sales of ¥8.35 billion for the nine months ended December 31, 2025, up 17.1% year on year, and moved into profitability with operating profit of ¥1.03 billion and profit attributable to owners of...
ExaWizards Subsidiary Files Clinical Trial Plan for Priority-Reviewed AI Cognitive Diagnostic Tool
Feb 4, 2026
ExaWizards’ wholly owned subsidiary ExaMD Inc. has submitted a clinical trial notification to Japan’s Pharmaceuticals and Medical Devices Agency for its AI-powered cognitive function diagnostic support software, a Software as a Medical...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.